Michael Fink is an HPB and liver transplant surgeon at the Austin Hospital, Melbourne and is associate professor in the University of Melbourne. He trained at St Vincent’s Hospital, Melbourne, the Queen Elizabeth Hospital, Birmingham, UK and Westmead Hospital, Sydney. His research interests include liver transplant waiting list mortality risk, organ allocation, complications of liver transplantation and treatment of hepatocellular carcinoma.